Enamel Matrix Derivative in Non-surgical Treatment of Peri-implant Mucositis
Peri Implant Mucositis
Enrolment: 54 · Results not recorded
Biologic · Biologic (enamel matrix proteins; not a discrete ChEMBL small molecule); periodontal regeneration
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
Peri Implant Mucositis
Enrolment: 54 · Results not recorded
Periodontal Defect
Enrolment: 40 · Results not recorded
1 studies reported at therapy level; 1 evidence entries itemised.
Model: Full-thickness mucoperiosteal flap (intracrevicular incision around upper first molar extended to palatal mucosa) creating an incisional wound on the palatal mucosa, split-mouth design with two wounds per animal
At day 1 wound closure was 75 plus or minus 3.8 per cent for EMD and 51 plus or minus 3.7 per cent for P2 versus 43 plus or minus 2 per cent for control and 44.8 plus or minus 3.4 per cent for TRAP; odds of wound closure rose 28 per cent with EMD (p less than 0.0001) and 12 per cent with P2 (p = 0.…
Extraction: extract · Supplied extraction confidence: 0.93. Machine-extracted fields require source verification.